Use of phospo-SRC expression as a predictive and prognostic biomarker in non-small cell lung cancer

被引：0
|
作者：
Kim, Lori C. [1 ]
Rawal, Bhupendra [2 ]
Schell, Michael J. [2 ]
Haura, Eric B. [1 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[2] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2009年 / 4卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S417 / S417
页数：1
相关论文
共 50 条
  • [31] Pre- and on-treatment lactate dehydrogenase as a prognostic and predictive biomarker in advanced non-small cell lung cancer
    Tjokrowidjaja, Angelina
    Lord, Sarah J.
    John, Thomas
    Lewis, Craig R.
    Kok, Peey-Sei
    Marschner, Ian C.
    Lee, Chee K.
    CANCER, 2022, 128 (08) : 1574 - 1583
  • [32] Expression of CDCA3 Is a Prognostic Biomarker and Potential Therapeutic Target in Non-Small Cell Lung Cancer
    Adams, Mark N.
    Burgess, Joshua T.
    He, Yaowu
    Gately, Kathy
    Snell, Cameron
    Zhang, Shu-Dong
    Hooper, John D.
    Richard, Derek J.
    O'Byrne, Kenneth J.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (07) : 1071 - 1084
  • [33] The Clinical and Pathological Significance of RCAS1 Expression as a Prognostic Biomarker in Non-small Cell Lung Cancer
    Tsoukalas, Nikolaos
    Kostakis, Ioannis D.
    Siakavellas, Spyros
    Giaginis, Constantinos
    Bournakis, Evangelos
    Sfiniadakis, Ioannis
    Karameris, Andreas
    Patsouris, Efstratios
    Theocharis, Stamatios
    IN VIVO, 2014, 28 (03): : 375 - 381
  • [34] Circulating Tumor DNA as a Prognostic Biomarker in Localized Non-small Cell Lung Cancer
    Peng, Muyun
    Huang, Qi
    Yin, Wei
    Tan, Sichuang
    Chen, Chen
    Liu, Wenliang
    Tang, Jingqun
    Wang, Xiang
    Zhang, Bingyu
    Zou, Min
    Li, Jina
    Su, Wenhui
    Wang, Lientu
    Chin, Lihan
    Yu, Fenglei
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [35] Prognostic and predictive biomarkers in non-small cell lung carcinoma
    Odintsov, Igor
    Sholl, Lynette m.
    PATHOLOGY, 2024, 56 (02) : 192 - 204
  • [36] Preoperative plateletcrit is a Prognostic Biomarker for Survival in Patients with Non-Small Cell Lung Cancer
    Hur, Joon Young
    Lee, Ha Yeon
    Chang, Hye Jung
    Choi, Cheon Woong
    Kim, Dae Hyun
    Eo, Wan Kyu
    JOURNAL OF CANCER, 2020, 11 (10): : 2800 - 2807
  • [37] miR-1290 is a potential prognostic biomarker in non-small cell lung cancer
    Mo, Dongping
    Gu, Bing
    Gong, Xue
    Wu, Lei
    Wang, Hong
    Jiang, Ye
    Zhang, Bingfeng
    Zhang, Meijuan
    Zhang, Yan
    Xu, Jian
    Pan, Shiyang
    JOURNAL OF THORACIC DISEASE, 2015, 7 (09) : 1570 - U302
  • [38] Overexpression of stathmin 1 is a poor prognostic biomarker in non-small cell lung cancer
    Nie, Wei
    Xu, Mi-die
    Gan, Lu
    Huang, Hai
    Xiu, Qingyu
    Li, Bing
    LABORATORY INVESTIGATION, 2015, 95 (01) : 56 - 64
  • [39] Predictive Significance of Thymidylate Synthase Expression in Non-small Cell Lung Cancer
    Kulda, Vlastimil
    Hrda, Kristyna
    Houdek, Zbynek
    Dobra, Jana Kolaja
    Vrzakova, Radana
    Svaton, Martin
    Safranek, Jarmil
    Dolezal, Jan
    Babuska, Vaclav
    Pesek, Milos
    Topolcan, Ondrej
    Pesta, Martin
    ANTICANCER RESEARCH, 2017, 37 (12) : 6953 - 6958
  • [40] Prognostic and predictive value of estrogen receptor 1 expression in completely resected non-small cell lung cancer
    Brueckl, Wolfgang Michael
    Al-Batran, Salah-Eddin
    Ficker, Joachim Hans
    Claas, Silke
    Atmaca, Akin
    Hartmann, Arndt
    Rieker, Ralf Joachim
    Wirtz, Ralph Markus
    INTERNATIONAL JOURNAL OF CANCER, 2013, 133 (08) : 1825 - 1831
12345